Skip to content
Disclosery

EXANE DERIVATIVES: CMI position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on CMI, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 356 CMI shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 356 shares
    Change vs previous 13F -2,322 shares

    0.04% of the 13F portfolio, value $68,889.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 2,678 shares
    Change vs previous 13F -170 shares

    0.15% of the 13F portfolio, value $549,296.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 2,848 shares
    Change vs previous 13F -366 shares

    0.15% of the 13F portfolio, value $621,291.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 3,214 shares
    Change vs previous 13F +87 shares

    0.18% of the 13F portfolio, value $721,769.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 3,127 shares
    Change vs previous 13F +1,118 shares

    0.18% of the 13F portfolio, value $755,159.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 2,009 shares
    Change vs previous 13F -666 shares

    0.16% of the 13F portfolio, value $520,580.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 2,675 shares
    Change vs previous 13F +2,396 shares

    0.18% of the 13F portfolio, value $607,524.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 279 shares
    Change vs previous 13F not available

    0.02% of the 13F portfolio, value $58,915.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).